Company Filing History:
Years Active: 1999
Title: The Innovations of Ronald Gebuhr
Introduction
Ronald Gebuhr is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid compounds. His work focuses on innovative solutions for medical treatments, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Ronald Gebuhr holds a patent for "17.alpha.-cyanomethylestra-4,9-dien derivatives and pharmaceutical." This patent describes a series of compounds that are particularly effective in treating endometriosis and gestagen-dependent tumors. The compounds are characterized by their unique chemical structure, which includes various alkyl and acyl groups. These derivatives are also suitable for hormonal contraception and climacteric hormone replacement therapy (HRT). The processes for synthesizing these new steroids and the methods for creating pharmaceutical compositions containing them are also detailed in his patent.
Career Highlights
Throughout his career, Ronald Gebuhr has been associated with Jenapharm GmbH, where he has contributed to various innovative projects. His work has not only advanced the field of pharmaceuticals but has also provided new treatment options for patients suffering from hormonal-related conditions. His dedication to research and development has made a lasting impact on the industry.
Collaborations
Ronald Gebuhr has collaborated with esteemed colleagues such as Gerhard Teichmuller and Gerd Muller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their research and development efforts.
Conclusion
In summary, Ronald Gebuhr is a distinguished inventor whose work in pharmaceutical innovations has led to significant advancements in medical treatments. His contributions continue to influence the field and improve patient care.